Loading...
Rapamycin does not inhibit human cytomegalovirus reactivation from dendritic cells in vitro
Human cytomegalovirus (HCMV) infection and reactivation are a major cause of morbidity in immune-suppressed patients. Interestingly, epidemiological studies have shown that patients administered the mammalian target of rapamycin (mTOR) inhibitor, sirolimus (rapamycin), exhibit more favourable outcom...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Society for General Microbiology
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4165932/ https://ncbi.nlm.nih.gov/pubmed/24986086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1099/vir.0.066332-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|